BRPI0418309A - géis coesos a partir de hialuronano e/ou hilano reticulados, sua preparação e uso - Google Patents

géis coesos a partir de hialuronano e/ou hilano reticulados, sua preparação e uso

Info

Publication number
BRPI0418309A
BRPI0418309A BRPI0418309-6A BRPI0418309A BRPI0418309A BR PI0418309 A BRPI0418309 A BR PI0418309A BR PI0418309 A BRPI0418309 A BR PI0418309A BR PI0418309 A BRPI0418309 A BR PI0418309A
Authority
BR
Brazil
Prior art keywords
hilane
relates
preparation
cohesive
gels
Prior art date
Application number
BRPI0418309-6A
Other languages
English (en)
Inventor
Adelya K Leshchiner
Paul A Konowicz
Valentina Vasilyeva
Original Assignee
Genzyme Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genzyme Corp filed Critical Genzyme Corp
Publication of BRPI0418309A publication Critical patent/BRPI0418309A/pt
Publication of BRPI0418309B1 publication Critical patent/BRPI0418309B1/pt
Publication of BRPI0418309B8 publication Critical patent/BRPI0418309B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates

Abstract

GéIS COESOS A PARTIR DE HIALURONANO E/OU HILANO RETICULADOS, SUA PREPARAçãO E USO. A presente invenção refere-se a feis altamente resilientes e coesos, formados pela reticulação de hialuronano ou hilano, seus sais ou derivados, usando divinil-sulfona (DVS) como agente reticulante. A invenção refere-se também a fluidos viscoeláticos que contêm grupos alquil-sulfona ligados de forma covalente à cadeia principal do polímero, formados pela monofuncionalização do monómero reticulante dvs com hialuronano e/ou hilano. As propriedades mecânicas, tais como dureza e coesão, são especificadas pelas propriedades reológicas dos géis. A invenção refere-se também a métodos para a preparação de tais produtos. Eles têm uso em muitas aplicações como dispositivos injetáveis e/ou implantáveis e como sistemas de distribuição de fármacos.
BRPI0418309A 2003-12-30 2004-12-30 "géis coesos de hialuronado e/ou hilano reticulados, processo para a preparação dos mesmos, bem como composições e dispositivos compreendendo os referidos géis". BRPI0418309B8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US53342903P 2003-12-30 2003-12-30
PCT/US2004/043811 WO2005066215A1 (en) 2003-12-30 2004-12-30 Cohesive gels form cross-linked hyaluronan and/or hylan, their preparation and use

Publications (3)

Publication Number Publication Date
BRPI0418309A true BRPI0418309A (pt) 2007-05-02
BRPI0418309B1 BRPI0418309B1 (pt) 2016-08-02
BRPI0418309B8 BRPI0418309B8 (pt) 2021-05-25

Family

ID=34748900

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0418309A BRPI0418309B8 (pt) 2003-12-30 2004-12-30 "géis coesos de hialuronado e/ou hilano reticulados, processo para a preparação dos mesmos, bem como composições e dispositivos compreendendo os referidos géis".

Country Status (10)

Country Link
US (1) US20050142152A1 (pt)
EP (1) EP1701981B1 (pt)
JP (2) JP5016926B2 (pt)
CN (1) CN100537606C (pt)
AU (1) AU2004312532B2 (pt)
BR (1) BRPI0418309B8 (pt)
CA (1) CA2550718C (pt)
IL (1) IL176465A (pt)
MX (1) MXPA06007556A (pt)
WO (1) WO2005066215A1 (pt)

Families Citing this family (82)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7338433B2 (en) 2002-08-13 2008-03-04 Allergan, Inc. Remotely adjustable gastric banding method
BR0306183A (pt) 2002-08-28 2004-10-19 Inamed Medical Products Corp Dispositivo de enfaixamento gástrico resistente à fadiga
FR2861734B1 (fr) 2003-04-10 2006-04-14 Corneal Ind Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus
EP1706044B1 (en) 2004-01-23 2011-10-05 Allergan, Inc. Releasably-securable one-piece adjustable gastric band
ES2333024T3 (es) 2004-03-08 2010-02-16 Allergan Medical S.A. Sistema de cierre para organos tubulares.
EP1732635B1 (en) 2004-03-18 2011-07-27 Allergan, Inc. Apparatus for volume adjustment of intragastric balloons
DK1817347T3 (en) * 2004-11-24 2017-08-14 Albumedix As Process for Crosslinking Hyaluronic Acid with Divinyl Sulfone
EP2664335A3 (en) * 2004-12-30 2015-12-16 Genzyme Corporation Regimens for intra-articular viscosupplementation
US8251888B2 (en) 2005-04-13 2012-08-28 Mitchell Steven Roslin Artificial gastric valve
US20070067045A1 (en) * 2005-09-19 2007-03-22 Ar2 Partners, Inc. Systems and methods for skin wrinkle removal
US7798954B2 (en) 2006-01-04 2010-09-21 Allergan, Inc. Hydraulic gastric band with collapsible reservoir
US8043206B2 (en) 2006-01-04 2011-10-25 Allergan, Inc. Self-regulating gastric band with pressure data processing
JP5399716B2 (ja) * 2006-03-02 2014-01-29 ノボザイムス バイオファーマ デーコー アクティーゼルスカブ アリール／アルキルビニルスルホンヒアルロン酸誘導体
FR2909560B1 (fr) 2006-12-06 2012-12-28 Fabre Pierre Dermo Cosmetique Gel d'acide hyaluronique pour injection intradermique
CA2687990A1 (en) * 2007-05-23 2008-12-04 Allergan, Inc. Cross-linked collagen and uses thereof
US8658148B2 (en) 2007-06-22 2014-02-25 Genzyme Corporation Chemically modified dendrimers
US8318695B2 (en) * 2007-07-30 2012-11-27 Allergan, Inc. Tunably crosslinked polysaccharide compositions
US8697044B2 (en) 2007-10-09 2014-04-15 Allergan, Inc. Crossed-linked hyaluronic acid and collagen and uses thereof
EP3498299A1 (en) 2007-11-16 2019-06-19 Aclaris Therapeutics, Inc. Compositions and methods for treating purpura
US8394784B2 (en) * 2007-11-30 2013-03-12 Allergan, Inc. Polysaccharide gel formulation having multi-stage bioactive agent delivery
US8394782B2 (en) * 2007-11-30 2013-03-12 Allergan, Inc. Polysaccharide gel formulation having increased longevity
US20090143348A1 (en) * 2007-11-30 2009-06-04 Ahmet Tezel Polysaccharide gel compositions and methods for sustained delivery of drugs
US8357795B2 (en) 2008-08-04 2013-01-22 Allergan, Inc. Hyaluronic acid-based gels including lidocaine
AU2015252122A1 (en) * 2008-08-04 2015-11-26 Allergan Industrie Sas Hyaluronic acid-based gels including anesthetic agents
EP3184552B1 (en) 2008-09-02 2020-08-12 Tautona Group LP Threads of hyaluronic acid, methods of making thereof and uses thereof
EP2341953B1 (en) 2008-09-04 2018-11-21 The General Hospital Corporation Hydrogels for vocal cord and soft tissue augmentation and repair
US20100305397A1 (en) * 2008-10-06 2010-12-02 Allergan Medical Sarl Hydraulic-mechanical gastric band
US8317677B2 (en) 2008-10-06 2012-11-27 Allergan, Inc. Mechanical gastric band with cushions
US20100185049A1 (en) 2008-10-22 2010-07-22 Allergan, Inc. Dome and screw valves for remotely adjustable gastric banding systems
FR2938187B1 (fr) * 2008-11-07 2012-08-17 Anteis Sa Composition injectable a base d'acide hyaluronique ou l'un de ses sels, de polyols et de lidocaine, sterilisee a la chaleur
US8390326B2 (en) * 2009-05-05 2013-03-05 William Marsh Rice University Method for fabrication of a semiconductor element and structure thereof
FR2945293B1 (fr) * 2009-05-11 2011-06-17 Teoxane Procede de preparation d'un gel reticule.
KR101551681B1 (ko) 2009-07-30 2015-09-09 카르빌란 테라퓨틱스, 인코포레이티드 변형된 히알루론산 폴리머 조성물 및 관련방법
US8273725B2 (en) * 2009-09-10 2012-09-25 Genzyme Corporation Stable hyaluronan/steroid formulation
US20110172180A1 (en) 2010-01-13 2011-07-14 Allergan Industrie. Sas Heat stable hyaluronic acid compositions for dermatological use
US20110171286A1 (en) * 2010-01-13 2011-07-14 Allergan, Inc. Hyaluronic acid compositions for dermatological use
US9114188B2 (en) 2010-01-13 2015-08-25 Allergan, Industrie, S.A.S. Stable hydrogel compositions including additives
US20110171311A1 (en) * 2010-01-13 2011-07-14 Allergan Industrie, Sas Stable hydrogel compositions including additives
US8758221B2 (en) 2010-02-24 2014-06-24 Apollo Endosurgery, Inc. Source reservoir with potential energy for remotely adjustable gastric banding system
US8840541B2 (en) * 2010-02-25 2014-09-23 Apollo Endosurgery, Inc. Pressure sensing gastric banding system
US9198568B2 (en) 2010-03-04 2015-12-01 The General Hospital Corporation Methods and systems of matching voice deficits with a tunable mucosal implant to restore and enhance individualized human sound and voice production
CA2792729C (en) 2010-03-12 2016-06-28 Allergan Industrie, Sas Fluid compositions for improving skin conditions
CA2794254C (en) 2010-03-22 2018-09-04 Allergan, Inc. Polysaccharide and protein-polysaccharide cross-linked hydrogels for soft tissue augmentation
US20110270024A1 (en) 2010-04-29 2011-11-03 Allergan, Inc. Self-adjusting gastric band having various compliant components
US9044298B2 (en) 2010-04-29 2015-06-02 Apollo Endosurgery, Inc. Self-adjusting gastric band
US9028394B2 (en) 2010-04-29 2015-05-12 Apollo Endosurgery, Inc. Self-adjusting mechanical gastric band
US20110270025A1 (en) 2010-04-30 2011-11-03 Allergan, Inc. Remotely powered remotely adjustable gastric band system
EP2575909B1 (en) * 2010-06-03 2020-01-15 Technology Innovation Momentum Fund (Israel) Limited Partnership Malleable hydrogel hybrids made of self-assembled peptides and biocompatible polymers and uses thereof
US8517915B2 (en) 2010-06-10 2013-08-27 Allergan, Inc. Remotely adjustable gastric banding system
US8716204B2 (en) 2010-07-27 2014-05-06 Zimmer, Inc. Synthetic synovial fluid compositions and methods for making the same
US8697057B2 (en) 2010-08-19 2014-04-15 Allergan, Inc. Compositions and soft tissue replacement methods
US8883139B2 (en) 2010-08-19 2014-11-11 Allergan Inc. Compositions and soft tissue replacement methods
US8889123B2 (en) 2010-08-19 2014-11-18 Allergan, Inc. Compositions and soft tissue replacement methods
US9005605B2 (en) 2010-08-19 2015-04-14 Allergan, Inc. Compositions and soft tissue replacement methods
US20120059216A1 (en) 2010-09-07 2012-03-08 Allergan, Inc. Remotely adjustable gastric banding system
NZ610346A (en) 2010-11-08 2015-06-26 Allergan Ind Sas Hyaluronic acid based formulations
US8961393B2 (en) 2010-11-15 2015-02-24 Apollo Endosurgery, Inc. Gastric band devices and drive systems
US9149422B2 (en) 2011-06-03 2015-10-06 Allergan, Inc. Dermal filler compositions including antioxidants
US20130096081A1 (en) * 2011-06-03 2013-04-18 Allergan, Inc. Dermal filler compositions
US9408797B2 (en) 2011-06-03 2016-08-09 Allergan, Inc. Dermal filler compositions for fine line treatment
US9393263B2 (en) 2011-06-03 2016-07-19 Allergan, Inc. Dermal filler compositions including antioxidants
PL2742070T3 (pl) 2011-08-10 2022-01-31 Glycores 2000 Srl Odporny na rozkład usieciowany hialuronian o niskiej masie cząsteczkowej
US9662422B2 (en) 2011-09-06 2017-05-30 Allergan, Inc. Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation
US20130244943A1 (en) 2011-09-06 2013-09-19 Allergan, Inc. Hyaluronic acid-collagen matrices for dermal filling and volumizing applications
KR20200116168A (ko) * 2011-09-14 2020-10-08 알러간, 인코포레이티드 잔주름 치료를 위한 진피 필러 조성물
CN102558600A (zh) * 2011-12-01 2012-07-11 上海白衣缘生物工程有限公司 交联透明质酸海绵及其制备方法
US8876694B2 (en) 2011-12-07 2014-11-04 Apollo Endosurgery, Inc. Tube connector with a guiding tip
US8961394B2 (en) 2011-12-20 2015-02-24 Apollo Endosurgery, Inc. Self-sealing fluid joint for use with a gastric band
JP6174690B2 (ja) * 2012-06-15 2017-08-02 メルツ ファーマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディト ゲゼルシャフト アウフ アクティーン ヒアルロン酸に基づく組成物の調製方法
US9579388B2 (en) 2012-11-29 2017-02-28 Rene Gauthier System and method for alleviating the appearance of scars and/or scar tissue
US9421198B2 (en) 2013-07-30 2016-08-23 Teoxane Composition comprising hyaluronic acid and mepivacaine
AU2015258997B2 (en) * 2014-05-16 2019-04-18 Ultrast, Inc. Phase-shifting formulations
WO2016051219A1 (en) 2014-09-30 2016-04-07 Allergan Industrie, Sas Stable hydrogel compositions including additives
WO2016128783A1 (en) 2015-02-09 2016-08-18 Allergan Industrie Sas Compositions and methods for improving skin appearance
AR105319A1 (es) 2015-06-05 2017-09-27 Sanofi Sa Profármacos que comprenden un conjugado agonista dual de glp-1 / glucagón conector ácido hialurónico
WO2017119198A1 (ja) * 2016-01-05 2017-07-13 デンカ株式会社 半月板変性治療用組成物
TW201832783A (zh) 2016-12-02 2018-09-16 法商賽諾菲公司 包含ｇｌｐ－１／胰高血糖素雙重激動劑、連接子和透明質酸的接合物
CN108250457A (zh) * 2017-05-08 2018-07-06 上海利康瑞生物工程有限公司 一种剪切粘度可控的双相交联透明质酸钠凝胶及其制备方法和制剂
US20190240335A1 (en) * 2018-02-07 2019-08-08 Promedon S.A. Biocompatible Hydrogel Compositions
KR20210041562A (ko) * 2018-08-07 2021-04-15 메르츠 파마 게엠베하 운트 코. 카가아 가교된 하이드로겔의 동적 여과 방법
WO2022051060A1 (en) * 2020-09-01 2022-03-10 Orthogenrx, Inc. Crosslinking of non-animal-derived hyaluronic acid with divinyl sulfone
TW202333793A (zh) 2022-01-11 2023-09-01 義大利商Ｇｐｑ有限公司 作為創新填充劑之新玻尿酸衍生物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE442820B (sv) * 1984-06-08 1986-02-03 Pharmacia Ab Gel av tverbunden hyaluronsyra for anvendning som glaskroppssubstitut
US4582865A (en) * 1984-12-06 1986-04-15 Biomatrix, Inc. Cross-linked gels of hyaluronic acid and products containing such gels
US4713448A (en) * 1985-03-12 1987-12-15 Biomatrix, Inc. Chemically modified hyaluronic acid preparation and method of recovery thereof from animal tissues
DE3684887D1 (de) * 1985-11-29 1992-05-21 Biomatrix Inc Arzneistoffabgabesysteme auf basis von hyaluronan, dessen derivaten und salzen sowie verfahren zu deren herstellung.
US4795741A (en) * 1987-05-06 1989-01-03 Biomatrix, Inc. Compositions for therapeutic percutaneous embolization and the use thereof
AU619760B2 (en) * 1987-12-10 1992-02-06 Genzyme Biosurgery Corporation Hylan preparation and method of recovery thereof from animal tissues
SE8900422D0 (sv) * 1989-02-08 1989-02-08 Pharmacia Ab Tvaerbundna hyaluronatgeler samt foerfarande foer framstaellning av dessa
US5246698A (en) * 1990-07-09 1993-09-21 Biomatrix, Inc. Biocompatible viscoelastic gel slurries, their preparation and use
US5143724A (en) * 1990-07-09 1992-09-01 Biomatrix, Inc. Biocompatible viscoelastic gel slurries, their preparation and use
CA2349168C (en) * 1998-11-10 2009-01-06 Denki Kagaku Kogyo Kabushiki Kaisha Hyaluronic acid gel, method of its production and medical material containing it
US6521223B1 (en) * 2000-02-14 2003-02-18 Genzyme Corporation Single phase gels for the prevention of adhesions
DE60120372T2 (de) * 2000-03-24 2007-07-05 Genentech Inc., San Francisco Verwendung von insulin zur behandlung von knorpelkrankheiten

Also Published As

Publication number Publication date
US20050142152A1 (en) 2005-06-30
WO2005066215A1 (en) 2005-07-21
AU2004312532B2 (en) 2010-05-20
CA2550718A1 (en) 2005-07-21
JP2012025955A (ja) 2012-02-09
IL176465A (en) 2013-07-31
CN100537606C (zh) 2009-09-09
EP1701981A1 (en) 2006-09-20
CN1902232A (zh) 2007-01-24
CA2550718C (en) 2013-11-05
BRPI0418309B1 (pt) 2016-08-02
AU2004312532A1 (en) 2005-07-21
BRPI0418309B8 (pt) 2021-05-25
MXPA06007556A (es) 2006-08-31
EP1701981B1 (en) 2017-06-07
JP2007519779A (ja) 2007-07-19
IL176465A0 (en) 2006-10-05
JP5680501B2 (ja) 2015-03-04
JP5016926B2 (ja) 2012-09-05

Similar Documents

Publication Publication Date Title
BRPI0418309A (pt) géis coesos a partir de hialuronano e/ou hilano reticulados, sua preparação e uso
You et al. Quaternized chitosan/poly (acrylic acid) polyelectrolyte complex hydrogels with tough, self-recovery, and tunable mechanical properties
Khong et al. Gelling Concept Combining Chitosan and Alginate Proof of Principle
Liu et al. Bioinspired adhesive hydrogel driven by adenine and thymine
Li et al. Self-healing hydrogel with a double dynamic network comprising imine and borate ester linkages
Li et al. Hybrid hydrogels with extremely high stiffness and toughness
Hong et al. Alginate‐boronic acid: pH‐triggered bioinspired glue for hydrogel assembly
Sun et al. Physical hydrogels composed of polyampholytes demonstrate high toughness and viscoelasticity
Li et al. Therapeutic-ultrasound-triggered shape memory of a melamine-enhanced poly (vinyl alcohol) physical hydrogel
Du et al. Tough and fatigue resistant biomimetic hydrogels of interlaced self-assembled conjugated polymer belts with a polyelectrolyte network
Waters et al. Structure and mechanism of strength enhancement in interpenetrating polymer network hydrogels
Baeva et al. Different molecular weight hyaluronic acid effects on human macrophage interleukin 1β production
Horkay et al. Osmotic swelling of polyacrylate hydrogels in physiological salt solutions
Shi et al. Elastic–plastic transformation of polyelectrolyte complex hydrogels from chitosan and sodium hyaluronate
Borzacchiello et al. Effect of hyaluronic acid amide derivative on equine synovial fluid viscoelasticity
BRPI0510428A (pt) composições tópicas de metadona e processos para utilização das mesmas
DK1163274T3 (da) Fremgangsmåde til tværbinding af hyaluronsyre til polymerer
BRPI0923336A2 (pt) Copolímeros zwiteriônicos
CY1105898T1 (el) Συνθεσεις υμενιου πηκτινης
BRPI0606675A2 (pt) agonista receptor de neuropeptìdio-2, composições farmacêuticas que compreendem o mesmo, compostos, método para o tratamento terapêutico e/ou profilático de enfermidades e utilização dos compostos
DE602006020256D1 (de) Geringe mengen hochmolekularer polymere zur viskositätserhöhung bei wässrigen/wässrig-zweiphasigen flüssigkeiten
BRPI0411071A (pt) sistemas de reticulação para polìmeros de hidroxila
BRPI0414017A (pt) pró-fármacos poliméricos de múltiplos braços
CZ2012537A3 (cs) Derivát kyseliny hyaluronové, způsob jeho přípravy, způsob jeho modifikace a použití
Xiong et al. Ultrahigh deformability and transparence of hectorite clay nanocomposite hydrogels with nimble pH response

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 02/08/2016, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 30/12/2004 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF